mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines

Patricia Freis(Centre National de la Recherche Scientifique), Carole Ferraro‐Peyret(Université Claude Bernard Lyon 1)
Oncotarget
February 18, 2017
Cited by 13


Related Papers